✦ LIBER ✦

Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial

✍ Scribed by Hiroshi Takahashi, Masashi Yamazaki, Akihiko Okawa…

Book ID: 120916165
Publisher: Springer
Year: 2012
Tongue: English
Weight: 203 KB
Volume: 21
Category: Article
ISSN: 0940-6719
DOI: 10.1007/s00586-012-2213-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective therapy using granulocyt

Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical trial

✍ Tsuyoshi Sakuma; Masashi Yamazaki; Akihiko Okawa; Hiroshi Takahashi; Kei Kato; M 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 291 KB

Neuroprotective therapy with granulocyte

Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control

✍ Kamiya, Koshiro; Koda, Masao; Furuya, Takeo; Kato, Kei; Takahashi, Hiroshi; Saku 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 238 KB

Intravenous administration of granulocyt

Intravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: a phase I and IIa clinical trial

✍ Kato, Kei; Yamazaki, Masashi; Okawa, Akihiko; Furuya, Takeo; Sakuma, Tsuyoshi; T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 356 KB

P166. The Cethrin Phase I/IIa Prospectiv

P166. The Cethrin Phase I/IIa Prospective Clinical Trial of a Cethrin for the Treatment of Acute Spinal Cord Injury

✍ Michael Fehlings; Nicholas Theodore; James Harrop; Gilles Maurais; Charles Kuntz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Neoadjuvant gene delivery of feline gran

Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial

✍ Cornelia Hüttinger; Johannes Hirschberger; Anika Jahnke; Roberto Köstlin; Thomas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract Despite aggressive pre‐ or postoperative treatment, feline fibrosarcomas have high recurrence rates. Immunostimulatory gene therapy is a promising approach in veterinary oncology. This phase I dose‐escalation study was performed to determine toxicity and feasibility of gene therapy with

Phase I Trial of Carboplatin, Paclitaxel

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

✍ Nadine Tung; Ross Berkowitz; Ursula Matulonis; Marc Quartulli; Michael Seiden; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 56 KB